Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost- Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States